Table 3: Patient characteristics by size of exposure.
|
Total (n = 41) |
< 1 cm exposure (n = 18) |
> 1 cm exposure (n = 23) |
p |
Median months to removal (IQR) |
42 (22-78) |
39 (24-91) |
45 (20-70) |
0.96 |
Median months follow-up (IQR) |
12 (2-25) |
12 (2-19) |
13 (1-44) |
0.60 |
Median age at surgery (IQR) |
54 (47-58) |
56 (47-62) |
53 (45-57) |
0.21 |
Race |
||||
Black |
2 (5%) |
0 (0%) |
2 (9%) |
0.75 |
Hispanic |
2 (5%) |
1 (6%) |
1 (4%) |
|
Other |
0 (0%) |
0 (0%) |
0 (0%) |
|
White |
37 (90%) |
17 (94%) |
20 (87%) |
|
Median BMI (IQR) |
27 (24-32) |
27.6 (25-32) |
27 (23-32) |
0.59 |
Obese |
14 (34%) |
7 (39%) |
7 (30%) |
0.74 |
Diabetes status |
||||
Non-diabetic |
35 (85%) |
16 (89%) |
19 (83%) |
0.65 |
Type 2 diabetes |
2 (5%) |
0 (0%) |
2 (9%) |
|
Insulin-dependent |
4 (10%) |
2 (11%) |
2 (9%) |
|
Median gravida (IQR) |
3 (2-3.5) |
2 (2-3) |
3 (2-4) |
0.29 |
Median parity (IQR) |
2 (2-3) |
2 (2-3) |
2 (2-3) |
0.60 |
Hormone replacement therapy (HRT) |
8 (24%) |
3 (20%) |
5 (26%) |
> 0.99 |
Menopausal status and HRT |
||||
Pre-menopausal |
21 (55%) |
8 (47%) |
13 (62%) |
0.48 |
Post-menopausal, no HRT |
12 (32%) |
7 (41%) |
5 (24%) |
|
Post-menopausal, on HRT |
5 (13%) |
2 (12%) |
3 (14%) |
|
Hysterectomy |
29 (81%) |
12 (80%) |
17 (81%) |
> 0.99 |
Smoking status |
||||
Ever smoker |
20 (49%) |
9 (50%) |
11 (48%) |
> 0.99 |
Never smoker |
21 (51%) |
9 (50%) |
12 (52%) |
|
Type of tape |
||||
Retropubic |
23 (56%) |
8 (44%) |
15 (65%) |
0.65 |
Obturator |
11 (27%) |
6 (33%) |
5 (22%) |
|
Mini sling |
2 (5%) |
1 (6%) |
1 (4%) |
|
Multiple slings |
5 (12%) |
3 (17%) |
2 (9%) |
|
Unknown |
0 (0%) |
0 (0%) |
0 (0%) |
|
Symptoms present |
||||
Voiding dysfunction |
18 (44%) |
8 (44%) |
10 (43%) |
> 0.99 |
Dyspareunia |
29 (71%) |
12 (67%) |
17 (74%) |
0.73 |
Pain |
24 (59%) |
7 (39%) |
17 (74%) |
0.031 |
Stress urinary incontinence |
19 (46%) |
9 (50%) |
10 (43%) |
0.76 |
Urgency urinary incontinence |
20 (49%) |
12 (67%) |
8 (35%) |
0.061 |
Mixed urinary incontinence |
14 (34%) |
6 (33%) |
8 (35%) |
> 0.99 |
Urinary tract infections |
17 (41%) |
7 (39%) |
10 (43%) |
> 0.99 |